Altimmune to present at the 4th annual nash summit 2020 digital conference

Gaithersburg, md., dec. 11, 2020 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that dr. scott harris, chief medical officer of altimmune will give an oral presentation on alt-801, the company's novel glp-1/glucagon dual receptor agonist in development for the treatment of non-alcoholic steatohepatitis (nash.) dr. harris will also participate on a panel discussion on nash treatments. the presentations will take place at the 4 th annual nash summit 2020 digital conference , which is being held december 15-18, 2020.
ALT Ratings Summary
ALT Quant Ranking